Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anamorelin
1. 861998-00-7
2. Anamorelin Hcl
3. Anamorelin (hydrochloride)
4. Anamorelin Hydrochloride [usan]
5. Rc-1291 Hcl
6. Rc-1291 Hydrochloride
7. 55f75ljq0v
8. (3r)-1-((2r)-2-((2-amino-2-methylpropanoyl)amino)-3-(indol-3-yl)propanoyl)-3-benzyl-n,n',n'-trimethylpiperidine-3-carbohydrazide Hydrochloride
9. 3-piperidinecarboxylic Acid, 1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-, Trimethylhydrazide, Monohydrochloride, (3r)-
10. Unii-55f75ljq0v
11. Ono-7643 Hydrochloride
12. Schembl4535148
13. Chembl2103794
14. Dtxsid70235443
15. Bcp15207
16. Anamorelin Hydrochloride (jan/usan)
17. Anamorelin Hydrochloride [mi]
18. Hy-14734a
19. Mfcd23098788
20. Anamorelin Hydrochloride [jan]
21. Akos030526940
22. Cs-1037
23. Anamorelin Hydrochloride [who-dd]
24. Ac-29222
25. D08856
26. Q27261306
27. 2-amino-n-((r)-1-((r)-3-benzyl-3-(1,2,2-trimethylhydrazine-1-carbonyl)piperidin-1-yl)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide Hydrochloride
28. 2-amino-n-[(2r)-1-[(3r)-3-benzyl-3-[dimethylamino(methyl)carbamoyl]piperidin-1-yl]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide;hydrochloride
Molecular Weight | 583.2 g/mol |
---|---|
Molecular Formula | C31H43ClN6O3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 582.3085169 g/mol |
Monoisotopic Mass | 582.3085169 g/mol |
Topological Polar Surface Area | 115 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 904 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of anorexia, cachexia or unintended weight loss in adult patients with non-small cell lung cancer (NSCLC)
Treatment of cancer related cachexia
V03
ABOUT THIS PAGE
A Anamorelin hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anamorelin hydrochloride, including repackagers and relabelers. The FDA regulates Anamorelin hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anamorelin hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anamorelin hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anamorelin hydrochloride supplier is an individual or a company that provides Anamorelin hydrochloride active pharmaceutical ingredient (API) or Anamorelin hydrochloride finished formulations upon request. The Anamorelin hydrochloride suppliers may include Anamorelin hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Anamorelin hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Anamorelin hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Anamorelin hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Anamorelin hydrochloride DMFs exist exist since differing nations have different regulations, such as Anamorelin hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Anamorelin hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Anamorelin hydrochloride USDMF includes data on Anamorelin hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Anamorelin hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Anamorelin hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anamorelin hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anamorelin hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anamorelin hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anamorelin hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anamorelin hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anamorelin hydrochloride suppliers with NDC on PharmaCompass.
Anamorelin hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anamorelin hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anamorelin hydrochloride GMP manufacturer or Anamorelin hydrochloride GMP API supplier for your needs.
A Anamorelin hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Anamorelin hydrochloride's compliance with Anamorelin hydrochloride specifications and serves as a tool for batch-level quality control.
Anamorelin hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Anamorelin hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anamorelin hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Anamorelin hydrochloride EP), Anamorelin hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anamorelin hydrochloride USP).
LOOKING FOR A SUPPLIER?